Chrisal

Chrisal is a biotechnology company specializing in the development of probiotic and synbiotic solutions for hygiene, healthcare, and personal care. The company's core technology utilizes beneficial bacteria to create a stable and healthy microbiome on surfaces and skin, effectively outcompeting harmful pathogens through competitive exclusion. Their products are primarily used in clinical settings to reduce the incidence of hospital-acquired infections and manage antibiotic-resistant biofilms. Following its acquisition by HeiQ in 2021, the company has integrated its microbial expertise into a broader range of textile and surface treatments. Chrisal remains a leader in sustainable, non-chemical microbial management for industrial and consumer applications.